No abstract available
MeSH terms
-
Adenocarcinoma / blood
-
Adenocarcinoma / complications
-
Adenocarcinoma / diagnosis
-
Adenocarcinoma / secondary
-
Aged
-
Anemia / drug therapy
-
Anemia / etiology
-
Anemia / therapy
-
Antifibrinolytic Agents / adverse effects
-
Antifibrinolytic Agents / pharmacology
-
Antifibrinolytic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Blood Coagulation / drug effects*
-
Carcinoma, Squamous Cell / blood
-
Carcinoma, Squamous Cell / complications
-
Carcinoma, Squamous Cell / secondary
-
Carcinoma, Squamous Cell / surgery
-
Cecal Neoplasms / blood
-
Cecal Neoplasms / complications
-
Cecal Neoplasms / diagnosis
-
Disseminated Intravascular Coagulation / drug therapy*
-
Disseminated Intravascular Coagulation / etiology
-
Fatal Outcome
-
Female
-
Fibrinogen / pharmacology
-
Fibrinogen / therapeutic use*
-
Fibrinolysis
-
Fluorouracil / administration & dosage
-
Heart Diseases
-
Hemorrhage / drug therapy*
-
Hemorrhage / etiology
-
Humans
-
Leucovorin / administration & dosage
-
Lung Neoplasms / blood
-
Lung Neoplasms / secondary
-
Lymphatic Metastasis / diagnosis
-
Multiple Organ Failure / etiology
-
Neoplasms, Multiple Primary / blood
-
Neoplasms, Multiple Primary / complications
-
Neoplasms, Multiple Primary / diagnosis
-
Organoplatinum Compounds / administration & dosage
-
Postoperative Complications / drug therapy
-
Postoperative Complications / etiology
-
Thrombosis
-
Tranexamic Acid / adverse effects
-
Tranexamic Acid / pharmacology
-
Tranexamic Acid / therapeutic use*
-
Vulvar Neoplasms / blood
-
Vulvar Neoplasms / complications
-
Vulvar Neoplasms / surgery
Substances
-
Antifibrinolytic Agents
-
Organoplatinum Compounds
-
Tranexamic Acid
-
Fibrinogen
-
Leucovorin
-
Fluorouracil